Structural and Functional Analysis of Cell Wall-Anchored PolypeptideAdhesin BspA in <i>Streptococcus agalactiae</i> by Rego, Sara et al.
                          Rego, S., Heal, T. J., Pidwill, G. R., Till, M., Robson, A., Lamont, R., ...
Nobbs, A. H. (2016). Structural and Functional Analysis of Cell Wall-
Anchored PolypeptideAdhesin BspA in Streptococcus agalactiae. Journal of
Biological Chemistry, 291(31), 15985-16000. DOI:
10.1074/jbc.M116.726562
Peer reviewed version
Link to published version (if available):
10.1074/jbc.M116.726562
Link to publication record in Explore Bristol Research
PDF-document
This is the author accepted manuscript (AAM). The final published version (version of record) is available online
via ASBMB at http://www.jbc.org/content/early/2016/06/15/jbc.M116.726562.abstract. Please refer to any
applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms.html
Streptococcus agalactiae BspA 
1 
 
 
Structural and Functional Analysis of Cell Wall-Anchored Polypeptide 
Adhesin BspA in Streptococcus agalactiae 
 
Sara Rego‡§, Timothy J. Heal§¶, Grace R. Pidwill‡, Marisa Till§||, Alice Robson§, Richard J. 
Lamont**, Richard B. Sessions§||, Howard F. Jenkinson‡, Paul R. Race§||1, and Angela H. Nobbs‡2 
 
From ‡School of Oral & Dental Sciences, University of Bristol, UK; §School of Biochemistry, University 
of Bristol, UK; ¶Bristol Centre for Functional Nanomaterials, University of Bristol, UK; ||BrisSynBio 
Synthetic Biology Research Centre, University of Bristol, UK; **Department of Oral Immunology and 
Infectious Diseases, University of Louisville, USA 
 
Running title: Streptococcus agalactiae BspA 
 
To whom correspondence should be addressed: 1Dr. Paul R. Race, School of Biochemistry, University of 
Bristol, Biomedical Sciences Building, University Walk, Bristol BS8 1TD, UK, Telephone: +44 
(0)1173311835, Email: Paul.Race@bristol.ac.uk. 2Dr. Angela H. Nobbs, School of Oral & Dental Sciences, 
University of Bristol, Lower Maudlin Street, Bristol, BS1 2LY, UK, Telephone:+44 (0)1173424779, Email: 
Angela.Nobbs@bristol.ac.uk. 
 
Keywords: adhesin, AgI/II polypeptide, Streptococcus, virulence factor, Candida albicans, 
crystallography, circular dichroism (CD), isothermal titration calorimetry (ITC), molecular dynamics 
 
 
ABSTRACT 
Streptococcus agalactiae (Group B 
Streptococcus, GBS) is the predominant cause of 
early-onset infectious disease in neonates and is 
responsible for life threatening infections in elderly 
and immune-compromised individuals. Clinical 
manifestations of GBS infection include sepsis, 
pneumonia and meningitis. Here we describe BspA, 
a deviant antigen I/II family polypeptide that 
confers adhesive properties linked to pathogenesis 
in GBS. Heterologous expression of BspA on the 
surface of the non-adherent bacterium Lactococcus 
lactis confers adherence to scavenger receptor 
gp340, human vaginal epithelium, and to the fungus 
Candida albicans. Complementary 
crystallographic and biophysical characterization 
of BspA reveal a novel β-sandwich adhesion 
domain and unique asparagine-dependent super-
helical stalk. Collectively these findings establish a 
new bacterial adhesin structure that has in effect 
been hijacked by a pathogenic Streptococcus 
species to provide competitive advantage in human 
mucosal infections. 
________________________________________ 
 
Streptococcus agalactiae (Group B 
Streptococcus, GBS) is a commensal of the 
gastrointestinal tract and part of the normal 
microbiota of the female rectovaginal tract, where 
it is carried asymptomatically by approximately 10-
40% of women of childbearing age (1). However, 
as an opportunistic pathogen, GBS is the leading 
cause of neonatal meningitis and sepsis in the 
developed world. The predominant route by which 
GBS is transmitted to infants is from the mother, 
either during birth or following breach of the 
placental barrier in utero. Antenatal GBS screening 
strategies are therefore commonly used to identify 
colonized women, who then receive antimicrobial 
prophylaxis. Nevertheless, GBS remains a major 
cause of morbidity and mortality in infants 
worldwide (2). 
Since maternal GBS colonization is the 
primary risk factor for vertical transmission of 
neonatal infection (3) there has been considerable 
focus on the mechanisms underlying GBS 
colonization of the female genitourinary (GU) tract. 
A number of putative colonization determinants 
have been identified including: alpha C protein, 
mediating entry of GBS into cervical epithelial cells 
(4); pili, shown to contribute to vaginal attachment 
(5); and Srr-1, which binds keratin-4 (5) and 
fibrinogen (6) on the surface of vaginal epithelium. 
In addition, GBS expresses numerous extracellular 
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matrix (ECM)-binding proteins, including C5a 
peptidase (ScpB) and FbsA, which may promote 
attachment to mucosal tissues of the GU tract (7). 
Antigen I/II (AgI/II) family polypeptide 
adhesins are found widely across the Streptococcus 
genus and have been best characterized for those 
streptococci indigenous to the oral cavity (8). In 
silico analyses have recently revealed the presence 
of genes encoding AgI/II family polypeptides in 
GBS, which we have designated here Group B 
Streptococcus surface proteins (Bsp). These 
proteins conform to a conserved primary structure 
consisting of seven distinct regions (Fig 1). The N-
terminal region comprises a signal (leader) peptide, 
an N-terminal domain and an alanine-rich repeat 
region (A). The C-terminal region consists of a 
proline-rich repeat sequence (P) followed by a C-
terminal domain (C) and an LPxTG motif required 
for bacterial cell wall anchorage. The A and P 
regions flank a central variable region (V), which 
exhibits the greatest strain-to-strain sequence 
variation between streptococci and is thought to 
confer ligand-binding specificity (8). Structural 
characterization of AgI/II family proteins from 
Streptococcus mutans (SpaP) and Streptococcus 
gordonii (SspB) has revealed a distinctive extended 
fibrillar structure that projects outwards from the 
wall-proximal C domain (Fig 1). The stalk is 
generated by a high affinity interaction between the 
α- and polyproline II (PPII)- helices of the A and P 
domains respectively, serving to present the V 
'head' domain at its tip (9). The N-terminus forms a 
stabilizing scaffold by wrapping behind the base of 
the stalk (10). Crystal structures of the V regions of 
SpaP and SspB have revealed a common 
architecture consisting of a lectin-like fold with a 
putative binding cleft (11,12). The structure of the 
C-terminal subdomains C1, C2 and C3 has also 
been elucidated by X-ray crystallography and found 
to consist of β-sandwich domains stabilized by 
isopeptide bonds (13-16). 
AgI/II family polypeptides are 
multifunctional adhesins that serve as important 
colonization determinants for oral streptococci, 
mediating binding to host substrata and to other 
resident microbes. A common receptor for AgI/II 
polypeptides is glycoprotein-340 (gp340), an innate 
immunity scavenger receptor produced at mucosal 
surfaces (17). Fluid-phase gp340, in saliva and 
other mucosal secretions, agglutinates microbes for 
clearance from the body, while solid-phase gp340 
adsorbed onto host surfaces provides a substratum 
for microbial adherence (18). AgI/II family 
polypeptides have also been shown to promote 
microbial community development by binding to 
oral bacteria Actinomyces oris (19-21) or 
Porphyromonas gingivalis (22,23), as well as to the 
pathogenic fungus Candida albicans (24). More 
recently an AgI/II family polypeptide (AspA) has 
been described in Group A Streptococcus (GAS) 
(25). The gene encoding AspA is located within an 
Integrative and Conjugative Element (ICE) 
designated Region of Difference 2 (RD2), which is 
found amongst GAS serotypes implicated in 
puerperal fever (26,27). There is strong evidence 
that RD2 originated in GBS and was acquired by 
GAS through horizontal gene transfer. It has been 
proposed that genes carried within RD2 might 
contribute to both GAS and GBS pathogenicity 
(28,29). Supporting this, AspA has been shown to 
facilitate GAS biofilm formation on salivary 
pellicle (25), respiratory infection, and evasion of 
phagocytosis (30). Given this precedent, we 
hypothesized that Bsp polypeptides may serve as 
important host colonization determinants of GBS.  
In this study we introduce four similar, but 
non-identical, Bsp family proteins that are 
distributed amongst GBS of different capsular 
serotypes. Crystallographic and biophysical 
characterization of isolated functional domains 
from one of these proteins (BspA) identifies unique 
structural features that distinguish it as an AgI/II 
family deviant. These findings are of significance 
in directing the development of new vaccines or 
anti-infective agents that selectively target GBS, 
whilst not impacting the commensal microbiota. 
 
RESULTS 
Distribution of AgI/II polypeptides in GBS 
In silico analyses were undertaken to determine the 
prevalence of bsp genes across GBS, using the 
completed GBS genome sequences available on 
NCBI. bsp genes were found in five strains 
(summarized in Table 1), and each was present on 
a RD2-like ICE (28). Based upon primary sequence 
identities, four homologues of the bsp gene were 
identified, which we designated bspA-D (Fig 1B). 
BspA shares 90.35% amino acid (aa) sequence 
identity with BspB, and both homologues were 
found in strain NEM316, which carries one copy of 
bspA and three copies of bspB. The remaining GBS 
strains carry either bspC or bspD. The proteins 
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encoded by these genes share 99.52 - 99.76% aa 
sequence identity, with the only major difference 
being that BspD is missing a leader peptide (39-41 
aa residues) for targeting to the Sec translocation 
machinery. BspA/B homologues can be separated 
from BspC/D homologues based upon the presence 
of two additional sequences in BspA/B 
homologues, one in the A domain (51 aa residues) 
and the second in the P domain (25 aa residues). 
There was no correlation between GBS capsular 
serotype and bsp homologue distribution. 
BspA promotes binding to immobilized 
gp340 
To investigate the functions of BspA as a putative 
colonization determinant in the absence of 
confounding problems due to adhesin redundancy 
in GBS, L. lactis was utilized as a heterologous 
expression strain. The bspA gene was cloned under 
control of a nisin-inducible promoter into vector 
pMSP (31), enabling expression of BspA to be 
regulated by the concentration of nisin added to the 
growth medium. Expression of BspA on the surface 
of L. lactis following nisin induction was confirmed 
by immuno-dot blot analysis (Fig 2A) with α-
Spy1325mid antibodies to S. pyogenes AspA mid-
region (25), which shares 63% aa sequence identity 
across corresponding VPC473-990 region of BspA. 
A primary host factor recognized by 
members of the AgI/II polypeptide family in oral 
streptococci and GAS is gp340, a mucin-like 
glycoprotein associated with the surface of mucosal 
tissues (17). When gp340 becomes adsorbed onto a 
surface, exposed cryptitopes can provide receptors 
for microbial adherence. To examine the interaction 
of BspA with gp340, binding levels of L. lactis 
expressing BspA (pMSP.bspA+) to immobilized 
gp340 were compared to L. lactis containing empty 
vector (pMSP), using a crystal violet 
spectrophotometric assay. Adhesion levels of L. 
lactis pMSP.bspA+ were significantly (P < 0.005) 
higher than those of L. lactis containing empty 
vector (Fig 2B). Furthermore, a dose-dependent 
response in binding to gp340 by BspA was seen 
with increasing nisin concentration. By contrast, 
neither L. lactis expressing BspA nor empty vector 
adhered to the blocking agent, bovine serum 
albumin (BSA). 
There is evidence that the head (V) regions 
of SspB, SpaP and AspA facilitate gp340-binding 
activity (9,25,32). To determine if the V domain of 
BspA plays a similar role in mediating binding to 
immobilized gp340, anti-V domain antibodies were 
affinity-purified from α-Spy1325mid antiserum 
(Fig 3A). These antibodies (designated α-rV.BspA) 
were then investigated for capacity to impair 
adherence of L. lactis pMSP.bspA+ to immobilized 
gp340. L. lactis expressing AgI/II family 
polypeptide SspB from S. gordonii was included as 
a control to confirm antiserum specificity. 
Lactococcal cells were labelled with FITC and 
binding to gp340 was measured using a 
fluorescence plate reader. Adherence of L. lactis 
pMSP.bspA+ cells to immobilized gp340 was 
significantly (P < 0.0001) impaired by α-rV.BspA, 
which reduced binding by 85% relative to the no 
antiserum control (Fig 3B). Importantly, this 
inhibition was specific to the reactivity of α-
rV.BspA antibody with BspA, as α-rV.BspA had no 
significant inhibitory effect on adherence of L. 
lactis pKS80.sspB+ to immobilized gp340 (Fig 3B). 
BspA interacts with C. albicans 
Previous studies have shown that SspB expressed 
by S. gordonii, an integral member of the human 
oral microbiota, interacts with C. albicans hyphal 
cell wall Als3 protein, promoting the development 
of mixed species communities (24). C. albicans co-
exists with GBS in the lower female GU tract, and 
several studies have observed recurrent co-isolation 
of GBS with C. albicans (33-35). To confirm the 
capacity for GBS to interact with C. albicans, 
FITC-labelled GBS NEM316 cells were incubated 
in suspension with hypha-forming cells of C. 
albicans SC5314 labelled with Calcofluor white, 
and aggregates were visualized by fluorescence 
microscopy. As reported for a number of oral 
streptococci (24,36-38), GBS NEM316 was shown 
to intimately interact with candidal cells, 
preferentially targeting C. albicans hyphal 
filaments rather than blastospores (Fig 4A). To 
determine if BspA was involved in promoting this 
association of GBS with C. albicans, the 
interactions of L. lactis expressing BspA or vector 
control (pMSP) with C. albicans were compared. L. 
lactis pMSP cells exhibited few interactions with C. 
albicans (Fig 4B). Similarly, uninduced L. lactis 
pMSP.bspA+ cells associated only sparsely with 
candidal hyphae (Fig 4C). By contrast, L. lactis 
cells induced to express BspA showed high affinity 
for C. albicans, and preferentially bound along the 
lengths of the hyphal filaments (Fig 4C). 
BspA promotes adhesion to human vaginal 
epithelium 
Streptococcus agalactiae BspA 
4 
 
 
GBS colonization of vaginal and cervical epithelia 
is the primary risk factor for vertical transmission 
of neonatal infection (3). To determine if BspA was 
a candidate for mediating GBS adherence to 
epithelial cells, binding levels of L. lactis 
pMSP.bspA+ to a vaginal epithelial cell line, 
VK2/E6E7, were compared to those of L. lactis 
pMSP vector control. Lactococci were incubated 
with VK2/E6E7 monolayers and numbers of 
associated bacteria enumerated by viable count. 
Numbers of L. lactis cells expressing BspA 
associating with VK2/E6E7 monolayers were 
significantly (P < 0.05) higher than vector control 
(Fig 5), implying that BspA mediates adhesion to 
vaginal epithelial cells. 
BspA possesses a truncated C-terminal 
domain that lacks bound metal ions 
To gain further insight into the adhesive properties 
of BspA we sought to structurally characterize this 
protein. Initially we focused our efforts on the 
BspA C-terminal domain (BspA-C, 328 aa 
residues). Although our whole cell binding studies 
identify the BspA variable domain as being 
responsible for gp340 binding by this polypeptide, 
a role for the C-terminal domain of AgI/II family 
polypeptides in target binding has been suggested 
by others (9,15,39). Despite being significantly 
shorter (328 aa residues as compared to 502-508 aa 
in other AgI/II family proteins), BspA-C domain 
exhibits a high degree of sequence identity to 
equivalent regions in other AgI/II family proteins, 
indicative of analogous function. The crystal 
structures of BspA-C and a more readily 
crystallizable point mutant of this protein, BspA-
CG744D (both comprising residues 554-881 of full 
length BspA), were determined by molecular 
replacement in the space groups C2122 and P212121 
respectively. The structure of BspA-CG744D was 
determined to 1.8 Å resolution using the SspB-
C1083-1413 crystal structure (13) (PDB code 2WOY, 
33% sequence identity) as a molecular replacement 
search model, and refined to a Rwork/Rfree of 
19.6/23.4%. The structure of BspA-C domain was 
determined to 2.2 Å resolution using the BspA-
CG744D structure as a molecular replacement search 
model and refined to a Rwork/Rfree of 21.8/23.9%. For 
both BspA-CG744D and BspA-C, the asymmetric 
unit comprises a single monomer of each protein. 
Crystal packing analysis reveals that Asp744 of 
BspA-CG744D forms a salt bridge with Lys855 in 
symmetry-related molecules. This interaction is 
likely to account for the increased propensity of 
BspA-CG744D to crystallize as compared to BspA-C. 
There are no significant structural differences 
between BspA-CG744D and BspA-C structures, with 
a Cα RMSD between the two structures of 0.5 Å 
(255 atoms). 
The final models of BspA-CG744D (334 aa 
residues, including 6 residues of the N-terminal 
vector encoded hexapeptide) and BspA-C (311 aa 
residues, lacking aa residues 640-657) are 
presented in Fig 6A and comprise a pair of compact 
subdomains (residues 554-725 and 726-881 of full-
length BspA) fused by a linker. The two 
subdomains are equivalent to those termed C2 and 
C3 in other AgI/II family polypeptides (13-16). The 
absence of a C1 subdomain, a feature that is present 
in all other AgI/II family proteins characterized to 
date, accounts for the size disparity between BspA-
C domain and other AgI/II family C domains. The 
C1-C2 interface region has been suggested as 
having a role in carbohydrate binding in the S. 
mutans AgI/II family protein SpaP (15). Its absence 
in BspA, and by inference from sequence analysis 
of BspB-D (Fig 1B) reveals that this interface 
region is not required for target ligand recognition 
or binding in Bsp family members. 
The two BspA-C subdomains consist of 
two central β-sheets, S1 and S2 in C2, and S3 and 
S4 in C3. S1 and S2 comprise four and five strands 
respectively. Strands β2 and β3 are connected by 
two short helices α1 and α2. Helix α6 runs parallel 
to α1 and α2 and connects β6 and β7. Helix α5 
protrudes from the core of the C2 subdomain 
connecting strands β5 and β6. Similarly to S1 and 
S2, the β-sheets S3 and S4 contain four and five 
strands respectively. Long loops connect strands at 
the interface of the C2 and C3 subdomains. Helix 
α7 connects strands β17 and β18. Strands β13 and 
β16 are connected by two short anti-parallel strands 
β14 and β15. Connecting loops are shorter on the 
opposite side of the sandwich, except for a long 
coiled region connecting β10 and β11. C2 and C3 
are connected by a long loop between strands β9 
and β10.  Protein-protein interactions at the C2-C3 
interface region are stabilized by a series of 
hydrogen bonds. Both C2 and C3 possess a single 
isopeptide bond (Fig 6A). In C2 this is formed 
between the side chains Lys556 (NZ) and Asn703 
(CG), and fuses S1 to S2. In C3 isopeptide bond 
formation occurs between Lys730 (NZ) and 
Asn861 (CG), linking S3 to S4. 
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Previously reported crystal structures of 
AgI/II family polypeptide C-terminal domains have 
identified the presence of bound metal ions, which 
have been suggested to play a role in enhancing 
stability and conferring adhesive properties (13-
16). By contrast no bound metal ions are observed 
in the crystal structures of BspA-CG744D or BspA-C. 
BspA-C2 subdomain does possess a putative 
unoccupied metal binding site, equivalently 
positioned to those reported in SpaP-C2, SspB-C2 
and AspA-C2. This site lies at the interface of the 
loop regions that connect β3 to β4 and β6 to α5, and 
comprises the residues Gln-607, Pro-608, Val-659 
and Glu-661. There is notable sequence disparity in 
the region of BspA-C3 that corresponds to the 
SpaP-C3 metal ion-binding site. The residues 
Asp1388 and Gln1391 in SpaP-C3, which act to 
coordinate a bound calcium ion, are found to be 
histidines in BspA-C3 (His-777 and His-780). In 
the AspA-C3 crystal structure (16) a single 
histidine substitution at the second of these 
positions (His-1205) appears sufficient to preclude 
metal ion binding. 
The BspA variable domain possesses a β-
sandwich fold that is structurally distinct from 
other AgI/II family polypeptides 
Having established the role of the BspA variable 
domain in gp340 binding we next sought to 
determine the crystal structure of this region of the 
protein. The structure of the BspA variable domain 
(BspA-V, comprising aa residues 285-451 of the 
full length protein) was determined in space group 
C2 using the SAD technique, as applied to crystals 
of SeMet labelled BspA-V. The structure was 
determined to a resolution of 2.4 Å and refined to a 
Rwork/Rfree of 23.5/26.2%. The asymmetric unit 
contains two copies of BspA-V arranged in the 
form of a strand-swapped homodimer (Fig 6B). 
BspA dimerization results from the exchange of the 
C-terminal β-strand (residues 436-606) of each 
monomer within the dimer. In full length BspA the 
N- and C-termini of the V domain are fused to their 
neighboring A and P domains (Fig 1A), an 
organization that would preclude BspA-V domain 
strand-swapping and implies that dimerization is an 
artifact of crystallization. The positioning of the 
exchanged C-terminal strands are however 
indicative of their location within the parent 
monomer. There are no significant structural 
differences between the monomers within the 
dimer, with an RMSD Cα between the two of 0.9 Å 
(141 atoms). Convincing electron density was not 
observed for residues 14-15 in monomer 1, and 11-
20 and 88-90 in monomer 2, and as such these 
regions have been excluded from our final model. 
BspA-V
 
adopts a fold that is distinct from 
those reported for other AgI/II family polypeptide 
V domains (11,12). This consists of two anti-
parallel β-sheets, S1 and S2, comprising 5 and 7 
strands respectively (Fig 6C). The two sheets are 
interconnected by four loops and the strands 
connected by five β-hairpins. There are ten β-
bulges in the structure (three G1 bulges, two wide 
bulges, and five classic β-bulges), of which six 
occur between strands, and four within β-hairpins. 
The six inter-strand β-bulges contribute to shaping 
the long central strands (β4, β5, β11 and β12) of the 
protein. In its monomeric form, the N- and C-
terminal strands of BspA-V (β1 and β12) would 
converge and be optimally positioned to connect 
the V domain with its partner A and P domains. 
An extended 17 aa residue linker between 
β1 and β2 projects outward from the surface of the 
protein exposing a large solvent accessible pocket 
(~500 Å3, as determined by CASTp (40)) located at 
the S1-S2 interface (Fig 6C and 6D). The pocket is 
populated by a combination of hydrophobic and 
negatively charged residues, consistent with a role 
in binding carbohydrates or glycoproteins, and is 
peripherally decorated with polar and negatively 
charged amino acids. Given the absence of any 
additional cavities, clefts, or highly charged 
surfaces, it is likely that this pocket constitutes the 
ligand binding site of BspA-V domain. The lack of 
compelling electron density for a number of the 
residues that constitute the loop linking strands β1 
and β2 implies that this region of the protein is 
flexible, suggesting that it may play a role in gating 
access to the BspA-V ligand binding pocket (Fig 6C 
and 6D). 
DALI analysis (41) identifies a single 
functionally analogous structural homologue of 
BspA-V domain, the carbohydrate binding protein 
RbmA from Vibrio cholerae (42). RbmA is a 
dimeric protein that promotes biofilm scaffolding 
via protein-carbohydrate interactions. In contrast to 
BspA-V, however, carbohydrate binding by RbmA 
is proposed to occur at either the interface of the 
RbmA dimer, or within a positively charged 
ordered loop present in each monomer. Both these 
structural features are absent in BspA-V implying 
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that the two proteins employ functionally distinct 
binding mechanisms. 
The BspA-A and -P domains form an anti-
parallel coiled-coil super-helix stabilized through 
an asparagine dependent hydrogen bond network 
Having elucidated the molecular structures of the 
BspA-V and -C domains we next turned our 
attention to the A and P domains of this protein. A 
common structural feature of AgI/II family 
polypeptides is the presence of an extended 
antiparallel coiled-coil super helix resulting from 
association of their A and P domains (9). This stalk-
like structure serves to project the V domain of the 
protein away from the bacterial cell surface, where 
the N and C domains are located, and in previously 
characterized AgI/II proteins arises due to the 
complementary “knobs-into-holes” packing of 
hydrophobic residues within the alanine-rich A 
domain and PxxP motifs present in the polyproline 
P domain (9). Bioinformatic analysis of the A and 
P domains from Bsp proteins demonstrates that 
these regions are significantly shorter than those of 
other AgI/II family polypeptides (117-168 residues 
for Bsp-A domains and 77-102 residues for Bsp-P 
domains) and differ considerably in amino acid 
composition. Most notably Bsp-A domains are 
largely devoid of the AxYxA(LV) heptad motif 
identified in SpaP and conserved in AspA and SspB 
(8). In an effort to reconcile these features the A and 
P domains of BspA were produced recombinantly 
and their ability to associate in vitro examined. 
Initially circular dichroism (CD) spectroscopy was 
used to monitor BspA-A/P association and assess 
changes in helicity resulting from coiled-coil 
formation. The CD spectrum of BspA-A is 
consistent with this domain adopting a 
predominantly α-helical structure, with >55% 
helicity as predicted using CDSSTR (43-47). 
BspA-P domain exhibits a CD spectrum consistent 
with an unfolded protein. Sequential titration of 
BspA-A into BspA-P, as monitored by CD 
spectroscopy, demonstrates a stepwise recovery in 
helicity, consistent with the formation of a coiled-
coil structure (Fig 7A). To further characterize the 
BspA-A/P interaction isothermal titration 
calorimetry (ITC) was used to monitor the 
thermodynamic parameters of BspA-A/P 
formation. Experiments titrating BspA-A into 
BspA-P were performed (Fig 7B). These analyses 
demonstrate that the BspA-A/P interaction is 
predominantly enthalpically driven with ∆G  = - 38 
± 4 kJ/mol, Ka= 4.3  ± 0.7 µM-1, Kd = 270 ± 3 nM, 
∆H= -660 ± 18 kJ/mol, ∆S = -2.1 kJ/mol/K, and n 
= 0.62 ± 0.01, at a temperature of 298 K. 
Next, we sought to demonstrate that BspA-
A/P domain mixing results in the formation of a 
single, tightly associated A/P complex. To 
investigate this the hydrodynamic properties of 
BspA-A, BspA-P and BspA-A/P domains were 
assessed using SEC (Fig 7C). Comparison of the 
elution profiles of recombinant BspA-A and BspA-
P with those of proteins of known molecular mass 
(Fig 7D) are consistent with masses of >30 kDa and 
>20 kDa respectively, significantly larger than 
those established by SDS-PAGE (Fig 7C). 
However, given that SEC elution behavior is 
dictated by Stokes radius rather than molecular 
mass (48), the elution behavior of BspA-A and 
BspA-P are consistent with both proteins being 
single species of extended conformation in 
solution. A BspA-A/P complex, generated by 
mixing BspA-A and BspA-P in near-equimolar 
quantities, yields a single species that elutes prior to 
both BspA-A and BspA-P domains. SDS-PAGE 
analysis of this species confirms the presence of 
both BspA-A and BspA-P domains in this species 
(Fig 7C). Together our spectroscopic, 
thermodynamic and hydrodynamic data are fully 
consistent with the ability of BspA-A and BspA-P 
domains to self-assemble to form a super-helical 
structure. 
In an effort to investigate the molecular 
basis of BspA-A/P complex formation a molecular 
model of this assembly was generated (Fig 7E). 
Inspection of this model suggests the BspA-A/P 
helical assembly is mediated largely via an 
asparagine seam, present on the A domain, which 
forms a series of complementary hydrogen bond 
interactions to main chain oxygen and nitrogen 
atoms within BspA-P domain. The BspA-A/P 
model remains extended over 200 ns of molecular 
dynamics simulations (Fig 8). To test the validity of 
our model an asparagine-less mutant of BspA-A 
domain was generated (BspA-A∆Asn) within which 
all 19 asparagines were substituted to alanines. 
BspA-A∆Asn exhibits a CD spectrum near-identical 
to that of BspA-A, demonstrating that the helical 
structure of BspA-A∆Asn is not perturbed by the 
Asp-Ala substitutions (Fig 7F). Titration of BspA-
A∆Asn into BspA-P, monitored using CD 
spectroscopy, reveals no increase in helicity. 
Similarly ITC (data not shown) and SEC analyses 
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(Fig 7G) provide no evidence of BspA-A∆Asn/P 
interaction or complex formation, illustrating the 
critical role of the BspA-A domain asparagine seam 
in BspA-A/P assembly. 
 
DISCUSSION 
GBS is a leading cause of severe, invasive 
bacterial infection and represents a significant 
global health and economic burden (2). Studies of 
the machineries employed by this bacterium to 
invade and colonize human hosts are thus of both 
broad fundamental interest and potential 
significance for informing the design of new 
therapeutic agents or interventions. AgI/II family 
polypeptides are important colonization 
determinants of oral viridans streptococci and have 
been identified in GBS (49,50). Our bioinformatic 
analyses demonstrate that five GBS strains, 
representing four capsular serotypes, carry genes 
encoding AgI/II family polypeptides, which we 
here designate as Bsp proteins. These data support 
a recent study in which the presence of ICEs 
carrying a bsp gene was shown to be prevalent 
across a collection of 303 GBS strains derived from 
11 host species, including humans, cattle and fish 
(50). Given the capacity for ICEs to undergo 
sequence deletions during mobilization, the 
frequency with which an intact bsp gene has been 
acquired by these strains supports the hypothesis 
and our findings here that Bsp proteins convey an 
important competitive advantage to GBS. Analysis 
of bsp gene sequences suggests that they conform 
to the canonical AgI/II family N-A-V-P-C domain 
architecture. Nonetheless, the significant sequence 
variations exhibited by Bsp proteins, as compared 
to other AgI/II family polypeptides (8), implies a 
disparity in both domain size and architecture, and 
hints at a diversification of function. 
AgI/II family polypeptides have been 
shown to play important roles in host colonization 
by facilitating binding interactions with epithelial 
cell surfaces (30,51,52). The ability of the 
archetypal Bsp family member BspA to facilitate 
binding to vaginal epithelial cells when presented 
on the surface of non-adherent bacterium L. lactis 
suggests a role for BspA, and perhaps other Bsp 
proteins, in facilitating host cell adherence and 
colonization. This has implications for disease risk 
associated with GBS carriage. Furthermore, a 
potential target for mucosal tissue colonization is 
identified as innate immune component gp340. 
BspA was shown to bind immobilized gp340 via a 
mechanism that appeared to be dependent upon the 
BspA-V domain. Vaginal epithelial cells express 
high levels of cell-associated gp340, and gp340 
targeting as a bridging molecule to support 
epithelial cell interactions has already been shown 
for HIV (53). Likewise attachment of GBS pili to 
immobilized gp340 within the oral cavity has been 
proposed as a potential mechanism to promote GBS 
colonization of the oropharynx of adults and 
neonates, an initial step in progression of invasive 
diseases (25,54). BspA-mediated interactions with 
immobilized gp340 may therefore represent an 
important mechanism for facilitating GBS 
colonization of infection-relevant sites. 
AgI/II family polypeptides of oral 
streptococci have been shown to promote bacterial 
cell interactions with other resident microbes, a 
process fundamental to the accretion of oral 
microbial biofilm communities. Likewise, 
colonization of the GU tract by the resident 
microbiota results from the formation of 
polymicrobial communities on the vaginal 
epithelium (55). This study provides the first 
evidence of interkingdom interactions between 
GBS and C. albicans. Given the reported co-
isolation of these two species (33-35), candidal-
GBS interactions may serve as an important 
mechanism to promote co-colonization of the GU 
tract. BspA-expressing L. lactis cells were shown to 
interact with C. albicans, binding preferentially to 
hyphal filaments. AgI/II family polypeptide SspB 
promotes S. gordonii binding to C. albicans hyphae 
via recognition of the hypha-specific adhesin Als3 
(24). A similar molecular mechanism may underpin 
the targeting of BspA to C. albicans hyphae. 
Our demonstration of the potential role of 
Bsp proteins in facilitating GBS colonization 
encouraged us to probe in greater detail the 
molecular determinants of target recognition by 
Bsp polypeptides. Although they retain the same 
general architecture as other AgI/II family proteins, 
the aa sequences of Bsp proteins suggested 
functional divergence. Our structural studies 
provide evidence for a mechanism of target binding 
that is distinct from other AgI/II family adhesins. 
The C-terminal domain of BspA lacks a discrete C1 
subdomain, proposed to enable the binding of 
carbohydrates or glycoproteins via the C1-C2 
interface. Further, the absence of bound metal ions, 
suggested in other AgI/II family polypeptide C-
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terminal domains to affect stability and adhesive 
properties (13-16), may indicate altered binding 
behavior. Although it is not possible to discount 
metal binding capability entirely based on our 
crystallographic studies, variations in aa 
composition within the C2 and C3 metal binding 
sites are consistent with loss of this function. As 
Bsp-V domain antibodies block BspA binding to 
gp340, it appears unlikely that Bsp-C domain 
makes any significant contribution to mediating 
this interaction. 
Our proposed role of BspA-V domain in 
target binding is consistent with studies of other 
AgI/II family polypeptides, where the V domain 
has been identified as a major determinant of 
adherence (8). The crystal structure of BspA-V 
domain demonstrates that this domain adopts a fold 
that is distinct from those reported for other AgI/II 
family polypeptides, comprising an elaborated β-
sandwich core, which exposes a sizeable binding 
pocket at the interface of its two constituent β-
sheets. The BspA-V domain has no structural 
precedent amongst AgI/II family proteins, or 
bacterial adhesins in general. The binding pocket of 
BspA is formed by a series of hydrophobic and 
negatively charged residues, consistent with a role 
in binding carbohydrates or glycosylated proteins. 
Gp340 is a highly complex molecule designed to 
recognize many microbial ligands. As such, gp340 
contains numerous N- and O-linked glycosylation 
sites together with multiple domains (SRCR, CUB) 
within the protein backbone (56). Given the 
architecture of BspA-V domain it is likely that 
gp340 recognition occurs at a site distinct to those 
targeted by other AgI/II family polypeptides. The 
role of Bsp proteins as multifunctional adhesins 
correlates with our findings that BspA targets 
gp340, vaginal epithelium and C. albicans, and is 
further supported by the recent evidence that BspC 
may contribute to biofilm formation (50). 
Alike to other AgI/II family polypeptides, 
Bsp proteins retain a coiled-coil super helical A/P 
domain stalk structure. In vitro assembly of the A/P 
domain complex unambiguously demonstrates that 
recombinant BspA-A and BspA-P domains self-
assemble to form a discrete BspA-A/P species, 
consistent with an elongated super-helix. However, 
Bsp proteins lack the defining sequence features 
observed in SpaP, SspB and AspA (9) that are 
involved in stabilizing the stalk via hydrophobic 
interactions. Our modelling studies highlight that 
the proposed assembly mechanism of SpaP and 
SspB A/P super-helices is not applicable to BspA. 
By contrast BspA-A/P assembly is facilitated 
through a hydrogen bond network primarily 
contributed to by asparagine residues present in 
BspA-A domain. The key role of these residues is 
further evidenced by the inability of an asparagine-
less BspA-A domain mutant to associate with 
BspA-P domain in vitro. As a result of shorter A/P 
stalk length and the absence of the C1 domain, 
BspA is predicted to be significantly shorter (25-35 
nm) than SpaP (>50 nm) (9). AgI/II family 
polypeptides in oral streptococcal species have 
been proposed to act as longer distance adhesins, 
making initial contacts with host surfaces (8). The 
shorter length of BspA may reflect that in GBS a 
two-step process occurs, whereby longer 
appendages carrying adhesins e.g. pili, establish 
primary host contacts, enabling BspA to make 
secondary interactions over shorter distances. 
In summary this study identifies BspA as 
an important adhesin of GBS that could play a 
pivotal role in facilitating host colonization. BspA 
binds to epithelial cell surfaces and to another 
opportunistic member of the human microbiota, C. 
albicans. The prototypical Bsp family member, 
BspA, is shown to possess a novel molecular 
architecture distinct from other AgI/II family 
proteins, including a unique functional variable 
domain with no structural precedent. This divergent 
structural configuration could be a key to assisting 
adhesion and survival of GBS in the presence of 
commensal streptococci or fungi. Moreover the 
structural and functional information that we 
describe for BspA can be developed towards 
designing novel therapeutics, not only against GBS, 
but also with potential to impact colonization by C. 
albicans. Vaccines or pharmaceuticals that worked 
efficiently by targeting this conserved antigen 
specific to GBS might therefore restrict host 
colonization or control invasive disease by these 
two opportunistic pathogens. 
 
EXPERIMENTAL PROCEDURES 
Bacterial strains and growth conditions 
Strains used in this study are outlined in Table 2. 
Escherichia coli K-12 MG1655 was used for 
molecular cloning experiments to generate 
pMSP7517-based constructs (abbr. pMSP), 
StellarTM competent cells were used to generate 
pOPINF-based constructs, and E. coli BL21(DE3) 
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was used for expression of recombinant proteins. 
The methionine auxotroph E. coli B834(DE3) was 
employed for expression of selenomethionine 
(SeMet) labelled proteins. All E. coli strains were 
cultured in Luria Bertani (LB) medium at 37 °C, 
with shaking at 220 rpm. Streptococcus strains were 
cultured in Todd-Hewitt broth containing 0.5% 
yeast extract (THY). All Streptococcus strains were 
grown at 37 °C in an atmosphere of 5% CO2. 
Lactococcus lactis strains were cultured in M17 
broth supplemented with 0.5% glucose (GM17) in 
a candle jar at 30 °C. Lactococci carrying nisin-
inducible pMSP-based constructs were subcultured 
into GM17 medium containing 10-100 ng/ml nisin. 
C. albicans SC5314 was cultivated on Sabouraud 
dextrose agar (SAB) at 37 oC for 48 h. Single 
colonies were used to inoculate YPD broth (2% 
yeast extract, 4% mycological peptone, 4% 
glucose) and cells were cultured at 37 °C with 
shaking at 220 rpm. Media were supplemented 
when necessary with 100 µg/ml ampicillin 
(Amp100) or 300 µg/ml erythromycin (Erm300) 
for E. coli; and 5 µg/ml erythromycin (Erm5) for 
lactococci. 
Generation of L. lactis heterologous 
expression strains 
Primers were designed to amplify locus 
GBS_RS06095 corresponding to full-length BspA 
(Table 3). NcoI and XhoI restriction sites were 
incorporated at the termini of forward and reverse 
primers respectively. PCR products were subcloned 
into nisin-inducible expression vector pMSP (31) 
via NcoI and XhoI sites, generating plasmid 
pMSP.bspA+. The construct was transformed 
directly into electrocompetent L. lactis NZ9800, 
prepared by culturing in GM17G broth (GM17 
broth supplemented with 2.5% glycine) at 30 °C to 
OD600nm 0.5-0.6. Cultures were incubated on ice for 
10 min, harvested by centrifugation (3000 g, 4 °C, 
10 min) and suspended in wash buffer (0.5 M 
glucose, 10% glycerol). Cells were electroporated 
in chilled electroporation cuvettes (2 mm electrode 
gap) using a Bio-Rad Gene Pulser set at 2.5 kV 
voltage, 25 µF capacitance and 400 Ω resistance. 
Transformants were recovered in SGM17MC 
medium (GM17 supplemented with 0.5 M sucrose, 
20 mM MgCl2 and 2 mM CaCl2), plated onto GM17 
agar supplemented with 5 µg/ml erythromycin and 
incubated for 48 h at 30 °C in a candle jar. 
Transformants were confirmed by plasmid isolation 
and PCR, while expression of BspA in L. lactis was 
verified by dot immunoblot. 
Dot immunoblot 
Expression of BspA on the surface of L. lactis was 
induced by culturing cells in the presence of 10-100 
ng nisin/ml. Suspensions were adjusted to OD600nm 
2.0 and spotted (2 µl) onto nitrocellulose 
membrane. The membrane was blocked with TBS 
(50 mM Tris-HCl, pH 7.2, 0.15 M NaCl) containing 
10% (w/v) milk powder, and subsequently probed 
with rabbit α-Spy1325mid (25) followed by swine 
anti-rabbit IgG-horseradish peroxidase (HRP) 
conjugate (Dako), both diluted 1 in 1000 into TBS 
supplemented with 0.1% Tween-20 and 1% milk 
powder. The membrane was then developed using 
AmershamTM ECLTM Western Blotting Analysis 
System (GE Healthcare) according to 
manufacturer’s instructions. 
In vitro gp340 binding assays 
Gp340 was prepared from parotid saliva samples 
pooled from multiple donors using a multi-step 
procedure including adsorption onto S. mutans 
cells, as described previously (18). Adherence of L. 
lactis cells expressing BspA to immobilized gp340 
was performed by crystal violet assay and data 
converted to cell numbers as previously described 
(25). 
Antibody inhibition assays 
Antibodies reactive against BspA-V (α-rV.BspA) 
were affinity purified from antibodies raised against 
AspA (α-Spy1325mid) (25) by a protocol adapted 
from Jenkinson et al., (1990) (57). Nitrocellulose 
membrane disks (4 cm diameter) were soaked in 
250 µl recombinant BspA-V (25 mg/ml) and left to 
dry for 10 min. Disks were blocked by incubating 
in TBS containing 10% (w/v) milk (TBSm) for 1 h, 
then washed with TBS and incubated for 3.5 h with 
3.5 ml α-Spy1325mid diluted 1 in 10 in TBSm. 
Residual antibody was collected for analysis and 
disks were washed 3 times in TBS. The disks were 
incubated in 3.5 ml 0.2 M glycine hydrochloride for 
8 min at 25 °C and then neutralized with 1 M 
K2HPO4. Dialysis into PBS (50 mM Na2HPO4-
NaH2PO4, pH 7.2, 0.15 M NaCl) was performed by 
concentrating antibodies with a 10 kDa 
concentrator (Vivaspin, GE Healthcare). 
Antibodies were stored at 4 °C. To check antibody 
specificity, recombinant proteins (see below) 
corresponding to BspA-V, BspA-P or BspA-C 
domains (0.6 mg/ml) were two-fold serially diluted 
and spotted onto nitrocellulose membrane. The 
blots were probed with antiserum α-Spy1325mid 
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(1:1000) or affinity purified α-rV.BspA (0.1 mg) 
and developed as described above. 
Coating of microtiter plate wells with 
gp340 was as described previously (25). Lactococci 
were harvested (5000 g, 7 min), washed in TBSC 
(TBS containing 5 mM CaCl2), resuspended in 1.5 
mM fluorescein isothiocyanate (FITC) in carbonate 
buffer (50 mM Na2CO3, 100 mM NaCl) and 
incubated for 1 h at 22 oC in the dark with gentle 
agitation. Cells were harvested (5000 g, 7 min), 
washed three times in carbonate buffer and 
suspended in TBSC at OD600nm 1.0. FITC-labelled 
L. lactis cells were incubated with or without 12.5 
µg α-rV.BspA for 30 min at 25 °C. Suspensions (50 
µl) were transferred to appropriate wells and 
incubated at 37 °C for 2 h. Wells were washed twice 
with TBS and fixed by adding 100 µl 25% 
formaldehyde for 30 min at 25 °C. Formaldehyde 
was removed and wells were washed twice with 
TBS before detection of binding levels using a 
fluorescence plate reader (excitation wavelength 
485 nm, emission wavelength 535 nm). 
C. albicans binding assays  
After 16 h growth in YPD, C. albicans cells were 
harvested (5000 g, 5 min), washed and resuspended 
in YNBPT (20 mM Na2HPO4-KH2PO4 pH 7.0, 1 x 
yeast nitrogen base [YNB], 0.02% tryptone) at 
OD600nm 1.0. Adjusted cell suspensions (200 µl; 2 x 
105 cells) were transferred to glass bijoux bottles 
containing 1.8 ml YNBPTG (YNBPT 
supplemented with 0.4% glucose) and incubated at 
37 °C, 220 rpm for 3 h to induce filamentation. 
Lactococci or GBS cells were harvested (5000 g, 7 
min), washed in YNBPT, FITC labelled as 
described above and suspended in YNBPTG at 
OD600nm 0.2. FITC-labelled bacteria (1 ml; 1 x108 
cells) were added to each bijoux containing hypha-
producing C. albicans and incubated at 37 °C, 220 
rpm for a further 1 h. Freshly prepared Calcofluor 
white (1 µg/ml final concentration) was added to 
each suspension just prior to depositing co-cultures 
(10 µl) onto microscope slides and visualizing by 
fluorescence microscopy. 
VK2/E6E7 binding assays 
Immortalized human vaginal (VK2/E6E7) 
epithelial cell lines were obtained from American 
Type Culture Collection (ATCC CRL-2616) and 
maintained at 37 °C with 5% CO2 in keratinocyte 
serum-free medium (KSFM; Gibco®) 
supplemented with 0.1 ng/ml human recombinant 
epidermal growth factor, 0.05 mg/ml bovine 
pituitary extract and 0.4 nM CaCl2. Bacterial 
association assays were performed as described by 
Sheen et al., (2011) (5), with minor modifications. 
In brief, VK2/E6E7 cells (105) were seeded into 24-
well plates and grown to confluence. Monolayers 
were then washed and incubated with L. lactis 
suspensions at a MOI of 5 for 2 h at 37 oC. 
Nonadherent bacteria were removed by washing, 
the monolayers were dispersed with trypsin/EDTA 
(0.1 ml), and then lysed with 0.025% Triton X-100 
in water (0.4 ml). Serial dilutions of this lysate were 
plated onto GM17 agar plates to enumerate 
associated bacterial colony forming units (CFU). 
Protein expression and purification 
Primers were designed to amplify regions of locus 
GBS_RS06095 corresponding to full-length BspA 
(BspA39-881), V domain (BspA-V285-451), C-terminal 
domain (BspA-C554-881), A domain (BspA-A117-284), 
and P domain (BspA-P452-553), and also a synthetic 
gene (MWG Eurofins) encoding a variant of the 
BspA-A domain within which all asparagine 
residues were substituted to alanine residues 
(BspA-A∆Asn) (Table 3). PCR products from 
amplification of GBS strain NEM316 chromosomal 
DNA were cloned into the pOPINF expression 
vector using the In-FusionTM recombinase 
(Clontech), incorporating a 6x His-tag at the N-
terminus of the cloned product. pOPINF was 
linearized as described previously (58). pOPINF 
and PCR amplicons were purified using a 
Nucleospin PCR Clean-up kit (Clontech) and 
ligated as instructed by the manufacturer’s 
protocol. All constructs were verified by DNA 
sequencing. A nucleotide substitution (2231G>A) 
was identified in bspA-C, resulting in a point 
mutation of Gly744 to Asp (G744D). This protein 
was designated BspA-CG744D. A new construct was 
subsequently generated lacking this mutation, 
which was designated BspA-C. 
Resulting plasmids were transformed into 
competent E. coli BL21(DE3) cells. Expression 
strains were grown in 1 L of LB medium to OD600nm 
0.4-0.6, at which time IPTG (0.2 mM final 
concentration for BspA-V and BspA-C; 1 mM for 
BspA, BspA-A, BspA-A∆Asn and BspA-P) was 
added and the culture incubated at 20 °C, 220 rpm 
for a further 16 h. Cells were harvested by 
centrifugation (5000 g, 15 min, 4 °C), washed in 
His-Load buffer (20 mM imidazole, 50 mM Tris, 
150 mM NaCl, pH 7.5) and cell pellets frozen at -
80 °C. 
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For SeMet substituted BspA-V, pOPINF-
bspA-V was transformed into competent E. coli 
B834(DE3) cells. Cells were grown to OD600nm 0.4-
0.6, harvested by centrifugation (5000 g, 15 min, 4 
oC), washed with distilled water to remove residual 
methionine and resuspended in 5 ml 50 mM Tris-
HCl, pH 7.5. This suspension was then used to 
inoculate 1 L of pre-warmed M9 medium 
containing 2.2% (w/v) SeMet Medium Base, 10.2% 
(w/v) Nutrient Mix and 0.014% (w/v) SeMet (all 
Molecular Dimensions Ltd.). The culture was 
grown to OD600nm 0.6, IPTG (0.2 mM final 
concentration) was added and the culture incubated 
at 37 oC with shaking for a further 16 h. Cells were 
harvested by centrifugation (5000 g, 15 min, 4 °C), 
washed in His-Load buffer supplemented with 1 
mM tris(2-carboxyethyl)phosphine-HCl (TCEP-
HCl, pH 7.5) and the cell pellet frozen at -80 °C. 
Frozen cell pellets were resuspended in 
His-load buffer supplemented with Pierce Protease 
inhibitor minitablets (Thermo Scientific). Cells 
were lysed by sonication and cellular debris was 
removed by centrifugation (20000 g, 30 min, 4 °C). 
Lysates were purified by nickel affinity 
chromatography using a HiTrap IMAC column (GE 
Healthcare), followed by size exclusion 
chromatography (SEC) using either a High Load 
16/60 Superdex 75 column (BspA-V, BspA-C; 
BspA-A, BspA-A∆Asn, BspA-P), or a Superdex 200 
column (BspA) (both GE Healthcare). 
Protein crystallization, data collection and 
processing 
BspA-CG744D, BspA-C and SeMet labelled BspA-V 
were concentrated to 17 mg/ml, 23 mg/ml and 25 
mg/ml respectively in buffer comprising 20 mM 
Tris, 150 mM NaCl, pH 7.5. SeMet labelled BspA-
V
 
crystals were grown in 0.1 M Buffer System 1 at 
pH 6.5 (MES, imidazole), 0.1 M amino acids and 
37.5% MPD_P1K_P3350 (Morpheus screen, 
Molecular Dimensions Ltd). BspA-CG744D crystals 
were grown in 0.1 M MMT buffer (1:2:2 L-malic 
acid, MES, Tris-HCl pH 6.0) and 25% (w/v) PEG 
1500. BspA-C crystals were grown in 0.02 M 
sodium/potassium phosphate and 20% (w/v) PEG 
3350. X-ray diffraction data were collected on 
beamlines I03 or I04 at Diamond Light Source, UK. 
Data for BspA-V and BspA-C were processed with 
MOSFLM (59). Data for BspA-CG744D were 
processed with XDS (60). All data collection and 
refinement statistics are provided in Table 4.   
Structure determination 
The structure of BspA-V
 
domain was determined 
using the single wavelength anomalous dispersion 
method (SAD) as applied to SeMet labelled crystals 
of BspA-V. Identification of heavy atom sites and 
the resulting initial phase calculation was carried 
out using PEHINIX AUTOSOL (61). This was 
followed by iterative rounds of manual model 
building and refinement using COOT (62) and 
REFMAC (63), the latter as implemented in the 
CCP4 suite of programmes (64). The final model of 
BspA-V
 
domain comprises two copies of the 
protein, each encompassing residues 285-451 of the 
native sequence, 64 water molecules, and 1 
molecule each of acetate, diethylene glycol, and 
ethylene glycol, 96.44% of residues are in allowed 
or favoured region of the Ramachandran plot with 
5 outliers (Lys-295, Asp-325, Val-327, Asp-348, 
Gln-370). 
The structure of BspA-CG744D was 
determined by molecular replacement using 
PHASER (65) employing the S. gordonii SspB-
C1083-1413 (13) as a search model (PDB code 2WOY, 
33% identity). The initial structure was subjected to 
iterative rounds of manual model building and 
refinement using COOT and REFMAC 
respectively. The final model of BspA-CG744D 
comprises one copy of the protein and 320 water 
molecules. 98.50% of residues are in allowed or 
favoured region of the Ramachandran plot; there 
were no outliers. 
The structure of BspA-C
 
domain was 
determined by molecular replacement using 
MOLREP (66) employing BspA-CG744D as a search 
model. Model building and refinement was 
performed as detailed above for BspA-CG744D. The 
final model of BspA-C
 
comprises one copy of the 
protein, 53 water molecules, 1 molecule of 
diethylene glycol, and 2 molecules of ethylene 
glycol, 96.10% of residues are in allowed or 
favoured region of the Ramachandran plot with one 
outlier (Asn-743). 
Circular dichroism spectroscopy 
CD spectra were collected using a Jasco 810 
spectropolarimeter (Jasco, Tokyo, Japan) fitted 
with a Peltier temperature controller. All spectra 
were collected from 190 to 260 nm, using a 1 mm 
pathlength cuvette, at 20 °C, in buffer comprising 
20 mM sodium phosphate, 50 mM sodium fluoride, 
pH 7.5. All proteins were dialyzed into this buffer 
prior to experimentation. Titration experiments 
were conducted by the sequential addition of BspA-
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P in 9.1 µl increments to BspA-A or BspA-A∆Asn, to 
a final concentration of 12.3 µM BspA-A and 11.7 
µM BspA-P respectively. Final spectra were 
generated as averages of 8 repeat scans, with 
appropriate protein-free buffer spectra subtracted. 
All data were plotted without smoothing using 
Excel. Spectra were analyzed using the 
DICHROWEB suite of programmes (46,47). 
Secondary structure predictions were performed 
using the CDSSTR method (43-47). 
Isothermal titration calorimetry 
Calorimetric titrations were performed using a 
MicroCal iTC200 system (GE Healthcare). The 
reaction cell (250 µl) contained BspA-A, BspA-
A∆Asn, or BspA-P domains at concentrations 
ranging from 4 to 12 µM. The syringe (40 µl) 
contained BspA-A, BspA-A∆Asn, or BspA-P at 
concentrations ranging from 48 to 130 µM. 
Experiments were carried out in reaction buffer 
comprising 20 mM sodium phosphate, 150 mM 
sodium chloride, pH 7.5, at 25 °C with a stirring 
speed of 800 rpm. All proteins were dialyzed into 
reaction buffer prior to experimentation. An initial 
injection of 0.4 µl (excluded from data fitting) was 
followed by 19 injections of 2.0 µl, separated by 
180 s intervals. Data were fitted with a single 
binding site model using Origin software (version 7 
with MicroCal ITC analysis module) permitting 
calculation of the thermodynamic properties ∆G, 
∆H, ∆S, Ka and stoichiometries (n) of the binding 
interactions. The enthalpy of dilution of the various 
titrants were measured by titration into buffer and 
found to be insignificant. 
Analytical size exclusion chromatography 
Analytical SEC was performed using a Superdex 75 
10/300 GL column (GE Healthcare) in buffer 
comprising 20 mM sodium phosphate, 150 mM 
NaCl, pH 7.5. 200 µl aliquots of each sample (20 
µM) were loaded onto the column and eluted at 0.5 
ml/min for 30 minutes. The absorbance of the 
column eluant was monitored at 280 nm 
throughout. 
Molecular modeling 
The only template for homology modelling the 
BspA-A/P domain is the S. mutans adhesin SpaP 
(PDB 3IOX). In this structure the seam between the 
α-helical (A) and PPII (P) components is formed by 
stretches of Asn sidechains interacting with the P 
backbone and stretches of Tyr residues 
interdigitating P proline sidechains. The BspA-A/P 
domain is about three times longer than the 
corresponding region in the 3IOX structure and the 
A domain is rich in Asn (10%) while poor in Tyr 
(2%). Mapping the sequence of BspA-A/P domain 
onto a template derived from 3 copies of the 3IOX 
A/P domain failed to capture many Asn to P 
backbone interactions due to supercoiling in the 
domain. Hence, an alternative approach was sought 
and an appropriate template was constructed in the 
following manner: Firstly a regular α-helix was 
built with the sequence BspA-A A71-N288 and 
flanked by 2 turns of glycine residues, resulting in 
a linear seam, comprising the majority of Asn 
residues, along one face of the helix. Copies of a 
short, Asn-rich section of the 3IOX A/P domain 
(A420-K446, P848-V861) were superimposed 
along the template helix, providing a guide to 
model the P domain from 3 copies of the 3IOX P 
domain with minimal adjustments of backbone 
torsion angles. The P domain sequence D452-T553 
was also flanked by glycine residues and 10 
registers of this P sequence were threaded onto the 
template, sidechains repacked with SCWRL (67) 
and the interaction energy of each thread evaluated 
with BUDE (68). The best energy model was 
prepared for energy calculations under the 
AMBER99-SB-ildn force field using the 
GROMACS tools to add hydrogen atoms consistent 
with pH 7, and surrounding the protein in a box of 
TIP3P waters containing 0.15 M sodium chloride. 
Molecular dynamics simulations (200 ns) were 
performed under periodic boundary conditions 
using PME electrostatics at 278 K and 1 bar as an 
NTP ensemble. The two components (A and P) 
were treated in the same way. Setup, simulations 
and analysis were performed using GROMACS 
4.6.7, structure processing and imaging with 
Chimera 1.9 and VMD 1.9.1. 
 Statistical analysis 
All data are reported as mean ± standard deviation 
(SD) unless otherwise indicated. Significance 
between samples was determined using the two-
tailed Student’s t-test, and a value of P <0.05 was 
accepted as indicating significance. Data were 
analyzed with GraphPad Prism v6 software. 
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FOOTNOTES 
The content is solely the responsibility of the authors and does not necessarily represent the official views 
of the NIH. 
 
The atomic coordinates and structure factors of BspA-V, BspA-CG744D and BspA-C have been deposited in 
the Protein Data Bank under accession codes 5DZ8, 5DZ9, 5DZA respectively. 
 
The abbreviations used are: GBS, Group B Streptococcus; GAS, Group A Streptococcus; ECM, 
extracellular matrix; Bsp, Group B Streptococcus surface protein; AspA, Group A Streptococcus surface 
protein; PPII, polyproline II; gp340, glycoprotein-340; RD2, region of difference 2; ICE, integrative 
conjugative element; SEC, size exclusion chromatography; SeMet, selenomethionine, RMSD, root-mean-
square deviation; SAD, single anomalous dispersion; ITC, isothermal titration calorimetry. 
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FIGURE LEGENDS 
 
FIGURE 1. (A) Model structure of Bsp family proteins based on the proposed domain organisation of 
other AgI/II polypeptides (8,9). This comprises a stalk consisting of the α-helical A domain and the 
polyproline II (PPII) helical P domain, separating the V domain and the C-terminal domains. The C-
terminal domain is followed by the LPxTG motif required for cell wall anchorage. (B) Amino sequence 
alignment of BspA, BspB, BspC and BspD. Structural regions are colored as in (A) with amino acids 
conserved in all four proteins highlighted in black. 
 
FIGURE 2. Interactions of BspA with immobilized gp340. (A) Dot immunoblot to verify the expression 
of BspA on the surface of L. lactis NZ9800. Lactococci were cultured for 16 h in the absence (uninduced) 
or presence of 10 ng/ml or 100 ng/ml nisin to induce BspA expression. Lactococcal suspensions (OD600nm 
2.0) were serially two-fold diluted and spotted onto nitrocellulose membrane. The blot was probed with α-
Spy1325 mid antibodies to the V region of AspA (25). (B) Binding of L. lactis pMSP.bspA+ or vector 
control (pMSP) to immobilized gp340. Induced or uninduced cells were then incubated in microwells 
coated with 50 ng gp340 (black column) or blocking agent BSA (grey column) for 2 h at 37 °C. Nonadherent 
cells were removed, and total biomass was measured by crystal violet staining. Values given represent mean 
± SD of three independent experiments performed in triplicate.*P < 0.005 relative to vector control, 
calculated using an unpaired Student’s t-test. 
 
FIGURE 3. Antibody inhibition binding studies. (A) Affinity purification of α-rV.BspA antibodies. 
Antibodies reactive against recombinant BspA-V (α-rV.BspA) were affinity purified from antibodies raised 
against AspA (α-Spy1325mid). Purified α-rV.BspA antibodies were used to probe dot immunoblots of 
serially diluted (1:2) recombinant proteins corresponding to BspA-V, P and C domains. Purified antibodies 
reacted only with BspA-rV. (B) Effects of affinity-purified antibody α-rV.BspA on adherence of L. lactis 
expressing BspA to immobilized gp340. L. lactis pMSP.bspA+ cells were FITC-labelled, preincubated 
without antibody or with 2.4 µg α-rV.BspA, and then incubated in microwells coated with 50 ng gp340 for 
2 h at 37 °C. Nonadherent cells were removed, and relative numbers of attached cells measured in a 
fluorescence plate reader. L. lactis pKS80.sspB+ expressing S. gordonii SspB was included as a control. 
Values given represent mean ± SD of two independent experiments performed in duplicate. *P < 0.0001 
relative to no antiserum (A/S) control, calculated using an unpaired Student’s t-test. 
 
FIGURE 4. Interactions of GBS or lactococci expressing BspA with C. albicans. (A) GBS NEM316 cells, 
(B) L. lactis pMSP vector control or (C) L. lactis pMSP.bspA+. L. lactis strains were cultured for 16 h in 
the absence (uninduced) or presence of 100 ng/ml nisin to induce BspA expression. GBS or L. lactis cells 
were FITC-labelled and incubated in suspension with hypha-forming cells of C. albicans stained with 
Calcofluor white. Aggregates were visualized by fluorescence microscopy. Scale bars, 20 µm. 
 
FIGURE 5. Interactions of L. lactis pMSP.bspA+ or pMSP vector control with VK2/E6E7 vaginal epithelial 
cell line. Lactococci (MOI 5) were incubated with monolayers of VK2/E6E7 cells and numbers of 
associated CFU enumerated from serial dilutions of recovered cell lysates. Values given represent mean ± 
SD of four independent experiments performed in triplicate.*P < 0.05 relative to vector control, calculated 
using a paired Student’s t-test. 
 
FIGURE 6. Crystal structures of BspA-V and -C domains. (A) Superposition of the crystal structures of 
BspA-CG744D (green) and BspC (blue). The location of the two isopeptide bonds are highlighted. (B) Crystal 
structure of the BspA-V strand-swapped homodimer. (C) Crystal structure of a BspA-V monomer. The 
domain adopts a β-sandwich fold, consisting of two anti-parallel sheets made-up of five and seven strands 
respectively. The N- and C-terminal strands meet to connect the V domain with A and P domains 
respectively. A close up view of the BspA-V target binding pocket is provided as an inset. The putative 
gating loop is labelled. For clarity, residues within the gating loop for which compelling electron density 
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was not observed (Asp298 and Asn299) have been excluded from the structure. (D) Electrostatic surface 
representation of BspA-V mirroring the views of the protein shown in (C). Electrostatic potentials were 
calculated using APBS (69). 
 
FIGURE 7. Biophysical characterisation of BspA-A/P complex formation. (A) CD spectroscopy of BspA-
A, BspA-P, and an equimolar mixture of both proteins. (B) ITC analysis monitoring the titration of BspA-
A into BspA-P. (C) SEC elution profiles of BspA-A, BspA-P and the BspA-A/P complex. (D) SEC column 
calibration curve calculated using Bio-Rad protein standards (thyroglobulin, 670 kDa; γ-globulin, 158 
kDa; ovalbumin, 44 kDa; myoglobin, 17 kDa; vitamin B12,
 
1.35 kDa). (E) Molecular model of the BspA-
A/P complex highlighting the role of BspA-A domain (blue) asparagine residues in mediating interaction 
with BspA-P (green). (F) CD spectroscopy of BspA-A∆Asn, BspA-P, and an equimolar mixture of both 
proteins. (G) SEC elution profiles of BspA-A∆Asn, BspA-P and an equimolar mixture of both proteins. 
FIGURE 8. Molecular dynamics simulations of the model of BspA-P/A, BspA-A and BspA-P. (A) 
Structures at time points during the simulations. The dimeric BspA-P/A model behaves as a semi-rigid rod 
during the simulation while the BspA-A α-helix shows kinking and partial unfolding of the helix. The PPII 
BspA-P rapidly collapses into a random coil. Ribbons are rainbow coloured blue N-terminal through red 
C-terminal. (B) Initial model. The alignment of most of the asparagine residues in BspA-A towards the 
backbone of BspA-P. Asn residues, pink spheres; Pro residues, magenta spheres. (C) Plots of radius of 
gyration with respect to time. BspA-A/P, red; BspA-A, green; BspA-P, blue. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Streptococcus agalactiae BspA 
20 
 
 
TABLE 1. Distribution of AgI/II family polypeptides in GBS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
AgI/II gene Strain (serotype) Previous locus tag New locus tag 
bspA NEM316 (III) gbs1143 GBS_RS06095 
 
bspB NEM316 (III) gbs0393 
gbs0723 
gbs0986 
GBS_RS02350 
GBS_RS04015 
GBS_RS05325 
 
bspC 515 (Ia) 
COH1 (III) 
SAL_2056 
SAN_2127 
SAL_RS04265 
GBSCOH1_1801 
 
bspD 2603V/R (V) 
18RS21 (II) 
SAG_2021 
SAJ_1924 
- 
- 
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TABLE 2. Microbial strains used in study 
 
Strain Characteristics Source 
S. agalactiae  NEM316 Wild-type (serotype III) Laboratory 
stock 
L. lactis NZ9800 Wild-type Laboratory 
stock 
UB2658 pMSP.bspA+ This study 
UB2635 Empty pMSP This study 
C. albicans  SC5314 Wild-type Gillum et al., 
1984 (70) 
E. coli K-12 MG1655 F- λ- rph-1 Laboratory 
stock 
 StellarTM F′ endA1 supE44 thi-1 recA1 relA1 gyrA96 phoA 
Φ80d lacZ∆ M15 ∆(lacZYA-argF) U169 ∆(mrr-
hsdRMS-mcrBC) ∆mcrA, λ- 
Clontech  
B834(DE3) F– ompT hsdSB(rB– mB–) gal dcm met (DE3) Novagen 
BL21(DE3) F– ompT hsdSB(rB– mB–) gal dcm (DE3) Novagen 
UB2878 pOPINF.bspA+; full-length; BL21 This study 
UB2879 pOPINF.bspA-V+; BL21 This study 
UB2880 pOPINF.bspA-C+; 2231G>A; BL21 This study 
UB2881 pOPINF.bspA-C+; BL21 This study 
 UB2882 pOPINF.bspA-A+; BL21 This study 
 UB2883 pOPINF.bspA-A∆Asn+; BL21 This study 
 UB2884 pOPINF.bspA-P+; BL21 This study 
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TABLE 3. Primers used in study 
aRestriction endonuclease sites are underlined. Sequences in bold indicate additional bases required for 
cloning into the ligation-independent expression vector pOPINF. 
 
 
 
 
 
 
 
 
 
 
Protein Product Primer Name Sequencea 
BspA1-932 
pMSP.bspA.F CATGCCATGGAGGAGGAAACAATATGAATTCAC 
pMSP.bspA.R CCGCTCGAGGCAACCCGATTATGAGAGG 
BspA39-881 
bspA-N.F AAGTTCTGTTTCAGGGCCCGGCTGATCAAGTTAC
AACTCAAGCA 
bspA-C.R ATGGTCTAGAAAGCTTTACTATTGCTCTCCTGTG
GATGGTAA 
BspA-V285-451 
bspA-V.F AAGTTCTGTTTCAGGGCCCGAATGTTGCTTTTGA
CATTAAAGCC 
bspA-V.R ATGGTCTAGAAAGCTTTACTAATTATTATTAACA
TAAGACACTAAAGC 
BspA-C554-881 
bspA-C.F AAGTTCTGTTTCAGGGCCCGCCAACTAAGAAAG
TTCTAGATGAA 
bspA-C.R ATGGTCTAGAAAGCTTTACTATTGCTCTCCTGTG
GATGGTAA 
BspA-A117-284 bspA-A.F AAGTTCTGTTTCAGGGCCCGATTAAAGATGCTAC
TGCTGAAAAT 
bspA-A.R ATGGTCTAGAAAGTCTTACTAATTAATAGACTGT
TTATCTGCTTC 
BspA-P452-553 bspP-A.F AAGTTCTGTTTCAGGGCCCGGATGCTGTTCCTAA
TGTGGTC 
bspP-A.R ATGGTCTAGAAAGCTTTACTATGTGGCCTTTGGT
ATCTGTAC 
BspA-A∆Asn bspA-A∆N-F AAGTTCTGTTTCAGGGCCCGATGGCGAAGAAAG
CGGCT 
 bspA-A∆N-R ATGGTCTAGAAAGCTTTATCAGGCAATCGACTGT
TTATCGGCTTC 
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TABLE 4. Crystallization, data collection and refinement statistics 
 
 
PDB IDs 
BspA-VSe-Met 
5DZ8 
BspA-CG744D 
5DZ9 
BspA-CWT 
5DZA 
Data collection    
Space group C121 P212121 C2221 
Cell dimensions 
   
a, b, c (Å) 148.1, 34.4, 92.6 38.1, 48.2, 234.1 34.1, 206.2, 121.4 
α, β, γ (°) 90.0, 127.3, 90.0 90.0, 90.0, 90.0 90.0, 90.0, 90.0 
Wavelength Å 0.979 0.979 0.920 
Resolution range (Å)a 73.7-2.4 (2.5-2.4) 58.5-1.9 (1.9-1.8) 39.1-2.2 (2.3-2.2) 
Rmerge 0.06 (0.14) 0.11 (0.84) 0.09 (0.45) 
I / σI 19.9 (8.6) 17.2 (3.4) 9.7 (1.9) 
CC1/2 (%) 99.8 (98.8) 99.7 (78.6) 99.6 (76.4) 
Completeness (%) 99.6 (97.2) 99.4 (96.4) 92.3 (94.3) 
Redundancy 5.9 (4.8) 12.3 (9.9) 3.4 (3.5) 
No. of Se sites 4 
  
FOM 0.25 
  
  
  
Refinement    
Resolution (Å) 73.7-2.4 55.5-1.9 102.9-2.2 
No. reflections 
(working set/test set) 
87362/13981 436280/33734 69391/19496 
Rwork / Rfree 23.5/26.2 19.6/23.4 21.8/23.9 
No. atoms 2566 2944 2505 
    Protein 2487 2624 2437 
    Ligand/ion 15 0 15 
    Water 64 320 53 
B-factors Å2 
   
    Protein 25 22 24 
    Ligand 30 
 
31 
    Water 29 32 24 
R.M.S. deviations 
   
    Bond lengths (Å) 0.02 0.02 0.02 
    Bond angles (°) 1.7 1.8 1.8 
    
aValues in parentheses are for highest resolution shell. 
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FIGURE 1. 
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FIGURE 2. 
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FIGURE 3. 
 
 
 
 
 
 
A
B
Streptococcus agalactiae BspA 
27 
 
 
FIGURE 4. 
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FIGURE 5. 
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FIGURE 6. 
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FIGURE 7. 
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FIGURE 8. 
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